{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:30:54Z","timestamp":1730871054587,"version":"3.28.0"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Introduction Whether psychiatric symptoms after recovery from coronavirus\n                    disease 2019 (COVID-19) are specific to this illness remains unclear.<\/jats:p><jats:p>\n          Methods In this retrospective study, the Diagnosis Procedure Combination\n                    data and outpatient clinic data were used for patients who received inpatient\n                    treatment in Saiseikai-affiliated hospitals for COVID-19 or other respiratory\n                    tract infections (non-COVID) from 2020 to 2022. The primary outcome was new\n                    prescriptions of psychotropic drugs after discharge (i.\u2009e., prescriptions of\n                    psychotropics to patients who had not received them before or during their\n                    hospitalization). Values of interest were compared between groups using the\n                    chi-square test or Fisher\u2019s exact test. A COX proportional-hazards model was\n                    used to examine factors associated with psychotropic prescriptions after\n                    discharge in age- and sex-matched COVID-19 and non-COVID patients.<\/jats:p><jats:p>\n          Results Of 31,993 chart records, 19,613 were excluded due to a positive\n                    history with psychiatric disorders (n=2,445), prescriptions of psychotropics\n                    (n=744), and no follow-ups (n=16,424). Thus, 3,648 COVID-19 and 8,732 non-COVID\n                    patients were included (mean [range] duration of follow-up, days: 146.9 [1\u2013727]\n                    and 239.2 [1\u2013729], respectively). Two hundred and four (5.6%) of the 3,648\n                    patients with COVID-19 received psychotropic prescriptions after discharge. No\n                    statistically significant differences were observed in the prescription rates of\n                    any psychotropic category between the COVID-19 and non-COVID groups. An increase\n                    in severity during hospitalization was significantly associated with more\n                    frequent psychotropic prescriptions (hazard ratio 1.83, p&lt;0.001).<\/jats:p><jats:p>\n          Discussion The development of psychiatric symptoms should be closely\n                    observed, especially in patients who experienced increased severity during\n                    hospitalization, regardless of whether they suffered from COVID-19.<\/jats:p>","DOI":"10.1055\/a-2286-1427","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T23:49:37Z","timestamp":1711496977000},"page":"186-190","source":"Crossref","is-referenced-by-count":0,"title":["Comparable Psychotropic Prescription Rates After Hospital Discharge\n                    Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory\n                    Infection"],"prefix":"10.1055","volume":"57","author":[{"given":"Yuna","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Drug Informatics, Keio University Faculty of Pharmacy,\n                    Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Yatomi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine,\n                    Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Saiseikai Research Institute of Health Care and Welfare, Tokyo,\n                    Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimio","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Keio University School of\n                    Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Hori","sequence":"additional","affiliation":[{"name":"Division of Drug Informatics, Keio University Faculty of Pharmacy,\n                    Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine,\n                    Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2215-0366(20)30307-2","article-title":"How mental health care should change as a consequence of the COVID-19\n                    pandemic","volume":"7","author":"C Moreno","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"J B Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1212\/WNL.0000000000200356","article-title":"Trajectories of neurologic recovery 12 months after hospitalization for\n                    COVID-19: A prospective longitudinal study","volume":"99","author":"J A Frontera","year":"2022","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1002\/jmv.27198","article-title":"Post-COVID syndrome: A single-center questionnaire study on 1007 participants\n                    recovered from COVID-19","volume":"93","author":"B Kayaaslan","year":"2021","journal-title":"J Med Virol"},{"key":"ref5","first-page":"611.e619","article-title":"Female gender is associated with long COVID syndrome: A prospective cohort\n                    study","volume":"28","author":"F Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fmb-2022-0031","article-title":"Long-term outcomes of pediatric infections: From traditional infectious diseases\n                    to long Covid","volume":"17","author":"D Buonsenso","year":"2022","journal-title":"Future Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e2134803","DOI":"10.1001\/jamanetworkopen.2021.34803","article-title":"Association of SARS-CoV-2 infection with psychological distress, psychotropic\n                    prescribing, fatigue, and sleep problems among UK primary care patients","volume":"4","author":"K M Abel","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","article-title":"Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre\n                    longitudinal study","volume":"27","author":"Q Xiong","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"E696","DOI":"10.9778\/cmajo.20220248","article-title":"Patient-reported outcomes of neurologic and neuropsychiatric symptoms in mild\n                    COVID-19: A prospective cohort study","volume":"11","author":"A Ganesh","year":"2023","journal-title":"CMAJ Open"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"100733","DOI":"10.1016\/j.lanepe.2023.100733","article-title":"Elevated symptoms of depression and anxiety among family members and friends of\n                    critically ill COVID-19 patients \u2013 an observational study of five cohorts across\n                    four countries","volume":"33","author":"A Lovik","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"102251","DOI":"10.1016\/j.eclinm.2023.102251","article-title":"Long-term symptom profiles after COVID-19 vs other acute respiratory infections:\n                    An analysis of data from the COVIDENCE UK study","author":"G Vivaldi","year":"2023","journal-title":"EClinicalMedicine"},{"volume-title":"R: A Language and Environment for Statistical Computing. In","year":"2021","author":"R Development Core Team","key":"ref12"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical\n                    statistics","volume":"48","author":"Y Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"101141","DOI":"10.1016\/j.cegh.2022.101141","article-title":"Post-COVID-19 mental health and its associated factors at 3-months after\n                    discharge: A case-control study","volume":"17","author":"A Azizi","year":"2022","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder:\n                    Retrospective cohort studies of 62\u2008354 COVID-19 cases in the USA","volume":"8","author":"M Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jad.2018.08.050","article-title":"Prevalence, treatment, and the correlates of common mental disorders in the mid\n                    2010\u2019s in Japan: The results of the world mental health Japan 2nd survey","volume":"241","author":"H Ishikawa","year":"2018","journal-title":"J Affect Disord"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/17476348.2015.1009041","article-title":"Impact of sleep quality on functional capacity, peripheral muscle strength and\n                    quality of life in patients with chronic obstructive pulmonary disease.","volume":"9","author":"N Vardar-Yagli","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/JAA.S345086","article-title":"Prevalence of insomnia among patients with bronchial asthma","volume":"15","author":"A Al-Harbi","year":"2022","journal-title":"J Asthma Allergy"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41380-022-01614-7","article-title":"A systematic review and meta-analysis of long term physical and mental sequelae\n                    of COVID-19 pandemic: Call for research priority and action","volume":"28","author":"N Zeng","year":"2023","journal-title":"Mol Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.euroneuro.2015.08.019","article-title":"A review of the current nomenclature for psychotropic agents and an introduction\n                    to the neuroscience-based nomenclature","volume":"25","author":"J Zohar","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2021.19499","article-title":"Association between mRNA vaccination and COVID-19 hospitalization and disease\n                    severity","volume":"326","author":"M W Tenforde","year":"2021","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","article-title":"Association between antidepressant use and reduced risk of intubation or death\n                    in hospitalized patients with COVID-19: Results from an observational study","volume":"26","author":"N Hoertel","year":"2021","journal-title":"Mol Psychiatry"},{"key":"ref23","first-page":"2318","article-title":"COVID-19 outcomes: Does the use of psychotropic drugs make a difference?\n                    Accumulating evidence of a beneficial effect of antidepressants\u2014a scoping\n                    review","volume":"25","author":"U Bonnet","year":"2022","journal-title":"J Clin Psychopharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/a-1717-2381","article-title":"Neuropsychiatric drugs against COVID-19: What is the clinical evidence?","volume":"55","author":"J K Mueller","year":"2022","journal-title":"Pharmacopsychiatry"}],"container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2286-1427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:16:57Z","timestamp":1730827017000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2286-1427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":24,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,7,9]]},"published-print":{"date-parts":[[2024,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2286-1427","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"type":"print","value":"0176-3679"},{"type":"electronic","value":"1439-0795"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}